21 C.F.R. § 630.10 - General donor eligibility requirements

Cite as21 C.F.R. § 630.10
CurrencyCurrent through December 7, 2020
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
18 practice notes
  • 817 F.2d 560 (9th Cir. 1987), 86-5578, Baker v. United States
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Ninth Circuit
    • May 18, 1987
    ...Sec. 2680(a) (emphasis added). The plaintiff in this case alleges the negligent failure of HEW to require the mandatory tests of 21 C.F.R. Sec. 630.10(b) 3 Page 563 Lederle was licensed to manufacture live, oral poliovirus vaccine in 1963 for release to the public. Baker contends that the f......
  • 661 F.2d 552 (6th Cir. 1981), 79-1725, Schindler v. United States
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Sixth Circuit
    • October 9, 1981
    ...of neurological illness has been demonstrated by blood tests (stool examinations and other appropriate methods, in violation of 21 CFR § 630.10(2)." [4] Because of the wording of 28 U.S.C. § 1346(b), supra, most courts consider the applicability of the discretionary function exception ......
  • 774 F.Supp. 952 (D.Md. 1991), MDL 780, In re Sabin Oral Polio Vaccine Products Liability Litigation
    • United States
    • Federal Cases United States District Courts 4th Circuit District of Maryland
    • September 20, 1991
    ...Drug Administration. I will also cite regulations from former volume 42 of the Code of Federal Regulations which currently appear at 21 C.F.R. §§ 630.10-630.17 [2] The plaintiff in Miller was exposed to shed virus from vaccine derived from seed 45 B 85, and the plaintiff in Musgrove was exp......
  • 984 F.2d 124 (4th Cir. 1993), 91-2398, In re Sabin Oral Polio Vaccine Products Liability Litigation
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Fourth Circuit
    • January 21, 1993
    ...et seq.; the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301 et seq.; and regulations, 42 C.F.R. §§ 73.110-73.118 (recodified as 21 C.F.R. §§ 630.10-630.17 (1991)). For consistency with the district court, we will refer to the regulations as originally I In Sabin I, 743 F.Supp. 410, t......
  • Request a trial to view additional results
15 cases
  • 817 F.2d 560 (9th Cir. 1987), 86-5578, Baker v. United States
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Ninth Circuit
    • May 18, 1987
    ...Sec. 2680(a) (emphasis added). The plaintiff in this case alleges the negligent failure of HEW to require the mandatory tests of 21 C.F.R. Sec. 630.10(b) 3 Page 563 Lederle was licensed to manufacture live, oral poliovirus vaccine in 1963 for release to the public. Baker contends that the f......
  • 661 F.2d 552 (6th Cir. 1981), 79-1725, Schindler v. United States
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Sixth Circuit
    • October 9, 1981
    ...of neurological illness has been demonstrated by blood tests (stool examinations and other appropriate methods, in violation of 21 CFR § 630.10(2)." [4] Because of the wording of 28 U.S.C. § 1346(b), supra, most courts consider the applicability of the discretionary function exception ......
  • 774 F.Supp. 952 (D.Md. 1991), MDL 780, In re Sabin Oral Polio Vaccine Products Liability Litigation
    • United States
    • Federal Cases United States District Courts 4th Circuit District of Maryland
    • September 20, 1991
    ...Drug Administration. I will also cite regulations from former volume 42 of the Code of Federal Regulations which currently appear at 21 C.F.R. §§ 630.10-630.17 [2] The plaintiff in Miller was exposed to shed virus from vaccine derived from seed 45 B 85, and the plaintiff in Musgrove was exp......
  • 984 F.2d 124 (4th Cir. 1993), 91-2398, In re Sabin Oral Polio Vaccine Products Liability Litigation
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Fourth Circuit
    • January 21, 1993
    ...et seq.; the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301 et seq.; and regulations, 42 C.F.R. §§ 73.110-73.118 (recodified as 21 C.F.R. §§ 630.10-630.17 (1991)). For consistency with the district court, we will refer to the regulations as originally I In Sabin I, 743 F.Supp. 410, t......
  • Request a trial to view additional results
3 provisions